This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish (read more).

Clinical Services

Contained Manufacturing

Our purpose built award-winning facility allows the manufacture of potent drug product in specially designed contained engineering equipment.



These state-of-the-art systems will safely process Active Pharmaceutical Ingredients (APIs) with a minimum Occupational Exposure Limit (OEL) of 0.01μg/ m3 based on an 8-hour time-weighted average. The design concept uses contained processing to minimize the need for Personal Protective Equipment (PPE) for routine operations.

We have adopted a clear design-for-manufacture approach with geometric scale-up to ensure reproducibility from development scale (1kg) to commercial scale (120kg) delivering true speed to market for our customers.

Our dedicated team of specialists will be happy to discuss any of your Contained Manufacturing needs. Contact us on +1 779-774-1428 (US) or +44 1495 711 222 (UK) or email sales@pciservices.com


Expansion of High Potent Tableting and Powder Modification Capacity

Investment in new technologies at PCI’s global manufacturing Center of Excellence in Tredegar, Wales, to double highly potent tableting capacity... View Article

PCI Welcomes New Chief Financial Officer and SVP, Serge Dupuis

PCI is pleased to welcome Serge Dupuis as Senior Vice President and Chief Financial Officer. Serge’s appointment supports PCI’s continued... View Article

x